Clarisse Melinda San Juan, MD
Pain Medicine · New Haven, CTNPI 1245750132
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Bioventus LLC at 28.8% of the total. Reporting peaked in 2023 at $1,937 and has fallen 78.8% since, to $410 in 2025.
Across 33 payments — averaging $107.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioventus LLC$1K
- Medtronic$948
- Abbott$559
- SPR Therapeutics, Inc$314
- Stratus Medical, LLC$127
- Nevro Corp.$125
- plus $450 from 5 others
What the payments were for
- Travel & lodging$1,50142%
- Food & beverage$2,04058%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioventus LLC | 2 | $1,018 |
| Medtronic | 9 | $948 |
| Abbott | 7 | $559 |
| SPR Therapeutics, Inc | 7 | $314 |
| Stratus Medical, LLC | 1 | $127 |
| Nevro Corp. | 2 | $125 |
| Saluda Medical Americas, Inc. | 1 | $117 |
| Arteriocyte Medical Systems, Inc. | 1 | $110 |
| Biotronik NRO, Inc. | 1 | $106 |
| Vertos Medical, Inc. | 1 | $80 |
| Pacira Pharmaceuticals Incorporated | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stimrouter Implantable Kit$1,018
- INTELLIS ADAPTIVESTIM$534
- ETERNA$445
- VANTA ADAPTIVESTIM$200
- Nimbus$127
- SPRINT PNS System$125
- Evoke$117
- Magellan$110
- Senza$107
- Prospera$106
How this compares
$3,541 in reported general payments places this provider in the 65th percentile of 69 pain medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 50 | $4,877 |
| Diclofenac Sodium | 189 | $4,471 |
| Celecoxib | 96 | $2,996 |
| Methocarbamol | 95 | $2,213 |
| Tizanidine Hcl | 198 | $1,954 |
| Gabapentin | 153 | $1,698 |
| Pregabalin | 81 | $1,598 |
| Cyclobenzaprine Hcl | 64 | $809 |
| Duloxetine Hcl | 36 | $466 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 31 | $417 |
| Meloxicam | 137 | $352 |
| Amitriptyline Hcl | 21 | $190 |
| Methylprednisolone | 15 | $108 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New Haven
- David GutierrezNew Haven$151K
- Yili HuangNew Haven$18K
- Daniel HaddadNew Haven$10K
- Robert ChowNew Haven$5K
- Kanishka RajputNew Haven$1K
- Ruchi SharmaNew Haven$890
- Lloyd SaberskiNew Haven$700
- Donna Ann ThomasNew Haven$524
- Colin Beals-ReidNew Haven$193
- Sandeep JoharWaterbury$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.